Purchase this article with an account.
Jieqiong Zhang, Zhifei Liu, Haoqian Wu, Xi Chen, Qiumei Hu, Xue Li, Linlin Luo, Shiyang Ye, Jian Ye; Irisin Attenuates Pathological Neovascularization in Oxygen-Induced Retinopathy Mice. Invest. Ophthalmol. Vis. Sci. 2022;63(6):21. doi: https://doi.org/10.1167/iovs.63.6.21.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
Abnormal angiogenesis is a defining feature in a couple of ocular neovascular diseases. The application of anti-VEGFA therapy has achieved certain benefits in the clinic, accompanying side effects and poor responsiveness in many patients. The present study investigated the role of irisin in retinal neovascularization.
Western blot and quantitative PCR were used to determine irisin expression in the oxygen-induced retinopathy mice model. The pathological angiogenesis and inflammation index were examined after irisin administration. Primary retinal astrocytes were cultured and analyzed for VEGFA expression in vitro. Astrocyte-conditioned medium was collected for transwell assay and tube formation assay in human microvascular endothelial cells-1.
Irisin was downregulated in the oxygen-induced retinopathy mice retinae. Additional irisin attenuated pathological angiogenesis, inflammation, and apoptosis in vivo. In vitro, irisin decreased astrocyte VEGFA production, and the conditioned medium suppressed human microvascular endothelial cells-1 migration. Last, irisin inhibited hypoxia-inducible factor-2α, nuclear factor-κB, and pNF-κB (Phospho-Nuclear Factor-κB) expression.
Irisin mitigates retinal pathological angiogenesis.
This PDF is available to Subscribers Only